Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVE: Ivermectin and Artemether-Lumefantrine for Malaria Transmission
NCT01603251Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2013
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivermectin in malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Jan 2013; status: completed.
02
Drugs
ivermectin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01603251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603251.